BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function
- PMID: 20142488
- PMCID: PMC2840147
- DOI: 10.1073/pnas.0915105107
BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function
Abstract
Natural fluctuations in circulating estradiol are associated with behavioral changes, including severe disturbances in mood and cognition in some women. Common genetic variation in some of the molecular mediators of estradiol effects on these behaviors, in brain regions such as the hippocampus, may explain individual variation in estradiol effects on behavior. We tested whether the common human variant BDNF Val66Met interacts with estradiol in the control of hippocampal function in cycling female mice homozygous for the wild-type Val or BDNF Met variant. BDNF Met increased anxiety behavior, impaired memory, and increased expression of BDNF and its receptor TrkB in the hippocampal formation. BDNF Met also dramatically altered the fluctuation of spatial memory, hippocampal Akt phosphorylation, and PSD-95 protein expression across the estrous cycle. The variant BDNF Val66Met should therefore be considered as a strong candidate for mediating genetic differences in ovarian steroid-related behavioral changes and disorders.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





References
-
- Protopopescu X, et al. Hippocampal structural changes across the menstrual cycle. Hippocampus. 2008;18:985–988. - PubMed
-
- Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage. 2004;21:364–371. - PubMed
-
- Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338:209–216. - PubMed
-
- Sherwin BB. Estrogen and cognitive aging in women. Neuroscience. 2006;138:1021–1026. - PubMed
-
- Sherwin BB, Tulandi T. “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab. 1996;81:2545–2549. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS07080/NS/NINDS NIH HHS/United States
- MH079513/MH/NIMH NIH HHS/United States
- R01 NS007080/NS/NINDS NIH HHS/United States
- P50 MH079513/MH/NIMH NIH HHS/United States
- R01 DA008259/DA/NIDA NIH HHS/United States
- P01 HL018974/HL/NHLBI NIH HHS/United States
- MH082528/MH/NIMH NIH HHS/United States
- R01 NS052819/NS/NINDS NIH HHS/United States
- F30 MH082528/MH/NIMH NIH HHS/United States
- NS052819/NS/NINDS NIH HHS/United States
- T32 GM007739/GM/NIGMS NIH HHS/United States
- DA08259/DA/NIDA NIH HHS/United States
- HL18974/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases